About Globavir

Globavir strives to develop medicines that will revolutionize the treatment of infectious diseases

Globavir's Infectious Disease pipeline includes GBV006, a broad spectrum antiviral being evaluated for the treatment of Chikungunya and Dengue infections

Globavir also offers best-in-class Dengue Diagnostic tests

Facts about Globavir
  • Founding: 2011
  • Focus : Service
  • Employees: 11-50
  • Industry : Pharma

Here you will find Globavir, Inc.